Mylan CEO testified before a House panel that EpiPen prices went up because of investing upgrades, according to NBC. » Read More
Insight to the regulatory process of pricing drugs, with Ian Read, Pfizer Chairman and CEO.
The JPMorgan Health Care Conference, which kicks off next week, could take on a more muted tone than in previous years.
CNBC's Meg Tirrell reports the latest news in the health care sector including Shire buying Baxalta for $32 billion and the formation of a new company to develop a blood test for cancer.
The Obama administration said recently that more than 11 million have signed up for health insurance. Experts see it differently.
Updated guidelines warn that consuming any amount of alcohol increases the risk to your health.
Mount Sinai Hospital's CEO told CNBC that while Obamacare survived a repeal attempt, it's locked in a tough game of numbers.
Virtual reality is the newest tech toy, but dizziness and other side effects could derail the momentum, says Doug Magyari.
Researchers have found that blocking a receptor in the brain that regulates immune cells could benefit the treatment of Alzheimer's.
An unknown number of Fitbit accounts reportedly have been breached by unidentified people who changed their settings.
A report commissioned by NASA discusses the risks of one of the agency's big goals: more human space travel.
Martin Shrekli is using a brokerage account to secure his $5 million bond to keep him out of jail as he fights fraud charges.
The Obama administration is looking to draw in more uninsured customers as open enrollment nears its Jan. 31 deadline.
Valeant Pharmaceuticals on Wednesday named Howard Schiller interim chief executive officer, effective immediately.
There hasn't been a significant increase in part-time jobs due to the Affordable Care Act.
Lumosity claimed its brain games could improve mental performance and stave off age-related cognitive decline.
Chipotle warned investors in a filing Wednesday that its comparable-restaurant sales nosedived 14.6 percent in the fourth quarter.
Get the best of CNBC in your inbox